References
- Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S. Central serous chorioretinopathy case-control study group. Risk factors for central serous chorioretinopathy: A case-control study. Ophthalmology 2004;111:244–249.
- Buhl AE, Waldon DJ, Baker CA, Johnson GA. Minoxidil sulfate is the active metabolite that stimulates hair follicles. J Invest Dermatol 1990;95:553–557.
- Andersson KE. Clinical pharmacology of potassium channel openers. Pharmacol Toxicol 1992;70:244–254.
- Burton JL, Marshall A. Hypertrichosis due to minoxidil. Br J Dermatol 1979;101:593–595.
- Lachgar S, Charveron M, Gall Y, Bonafe JL. Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells. Br J Dermatol 1998;138:407–411.
- Li M, Marubayashi A, Nakaya Y, Fukui K, Arase S. Minoxidil-induced hair growth is mediated by adenosine in cultured dermal papilla cells: Possible involvement of sulfonylurea receptor 2B as a target of minoxidil. J Invest Dermatol 2001;117:1594–1600.
- Rastmanesh R. Alopecia and ocular alterations: A role for minoxidil? J Recept Signal Transduct Res 2010;30:189–192.
- Tsuboi R, Arano O, Nishikawa T, Yamada H, Katsuoka K. Randomized clinical trial comparing 5% and 1% topical minoxidil for the treatment of androgenetic alopecia in Japanese men J Dermatol;2009;36:437–446.
- Rodriguez-Matin M. Pustular allergic contact dermatitis from topical minoxidil 5% J Eur Acad Dermatol Venereol. 2007;21:701–702.
- Satoh H, Morikaw S, Fujiwara C, Terada H, Uehara A, Ohno R. A case of acute myocardial infarction associated with topical use of minoxidil (RiUP) for treatment of baldness. Jpn Heart J 2000;41:519–523.
- Smorlesi C, Caldarella A, Caramelli L, Di Lollo S, Moroni F. Topically applied minoxidil may cause fetal malformation: A case report. Birth Defects Res Part A Clin Mol Teratol 2003;67:997–1001.
- De ClementiC. Suspected toxicosis after topical administration of minoxidil in 2 cats. J Vet Emerg Crit Care 2004;14:287–292.
- Bernasconi P, Messmer E, Bernasconi A, Thölen A. Assessment of the sympatho-vagal interaction in central serous chorioretinopathy measured by power spectral analysis of heart rate variability. Graefes Arch Clin Exp Ophthalmol 1998;236:571–576.
- JamesT. Handa Inhibition of cultured human RPE cell proliferation and lysyl hydroxylase activity by hydroxy derivatives of minoxidil. Invest Ophthalmol Vis Sci. 1994;35:463–9.
- Lim JW, Kim MU. The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2011;249:969–974.